POTOMAC, MD / ACCESSWIRE / January 8, 2025 / IGC Pharma, Inc. (NYSE American:IGC) ("IGC Pharma" or the "Company") announced today that its ongoing Phase 2 trial for agitation in Alzheimer's disease ...
In May 2024, the Pentagon offered a glimpse into the program after months of keeping details under wraps. The DOD announced that AeroVironment’s Switchblade-600 loitering munitions were included in ...